TipRanks on MSN1d
Electrovaya price target lowered to $10 from $16 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Electrovaya (ELVA) to $10 from $16 and keeps a Buy rating on the shares. The company’s revenue guidance for fiscal 2025 of $60M come in lower than ...
Keros Therapeutics price target lowered to $47 from $100 at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Keros Therapeutics (KROS) to $47 from $100 and keeps a Buy rating on the ...
bovnews18h
Stock Shock: The Unpredictable Rise and Fall of UUUU—What’s Driving the Drama?
On Thursday, Energy Fuels Inc (UUUU) stock saw a decline, ending the day at $6.16 which represents a decrease of $-0.24 or -3.75% from the prior close of $6.4. The stock opened at $6.35 and touched a ...
iTeos Therapeutics price target lowered to $21 from $46 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on iTeos Therapeutics (ITOS) to $21 from $46 and keeps a Buy rating on the shares. The firm ...
Hosted on MSN15d
Splash Beverage price target lowered to 50c from $1 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares ...
bovnews19h
What’s Causing Sangamo Therapeutics Inc (SGMO) Stock’s 243.15% Jump Over the Last Six Months?
Sangamo Therapeutics Inc (SGMO) stock saw a decline, ending the day at $1.91 which represents a decrease of $-0.03 or -1.55% from the prior close of $1.94. The stock opened at $1.9 and touched a low ...
Nasdaq1mon
Ocuphire Pharma rating placed under review at H.C. Wainwright
H.C. Wainwright placed the firm’s Buy rating on Ocuphire Pharma (OCUP) under review saying the acquisition of Opus Genetics starts a new chapter. The views and opinions expressed herein are the ...
Nasdaq19d
BridgeBio price target raised to $49 from $43 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on BridgeBio (BBIO) to $49 from $43 and keeps a Buy rating on the shares. Acoramidis received regulatory approval with the label underscoring ...
Yahoo Finance25d
Eyenovia downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded Eyenovia (EYEN) to Neutral from Buy with a price target of $2, down from $12. Based on the announced independent data review committee determining the Phase 3 CHAPERONE ...
Yahoo Finance18d
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
today announced that the Company will participate in the virtual H.C Wainwright @ Home fireside chat series taking place on Tuesday, December 3, 2024 at 11:00 am ET. To access the live webcast of ...
Investing26d
H.C. Wainwright keeps Buy rating on Cytokinetics shares, citing promising data on aficamten and omecamtiv
On Monday, H.C. Wainwright reaffirmed a Buy rating with a $120.00 price target on shares of Cytokinetics (NASDAQ:CYTK). The firm's endorsement follows presentations at the 2024 American Heart ...
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...